CHU Toulouse
Toulouse, 31000, France
NCT Number: NCT06695546
Venous overload has an impact on peripheral organ perfusion and on the short- and long-term prognosis of intensive care patients. The VExUS ultrasound score is a new tool whose parameters can be used to estimate this impact. This score was initially evaluated and validated on an adult population. ) In children, there is only one study looking at the use and applicability of this VExUS score, highlighting its feasibility in a paediatric population, as well as a possible correlation between elevated central venous pressure and altered renal Doppler (one of the score's components).
Looking for future studies?
Notify Me1 year–18 year
All sexes
Observational
Toulouse, 31000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Children aged between 1 and 18 years, receiving extrarenal purification with UF > 10 ml/kg, bleeding > 10 ml/kg or vascular filling > 10 ml/kg
Exclusion criteria
VExUS evaluation by ultrasound will be performed before the filling/bleeding/cleaning procedure, and again after the procedure:
Time frame: 10 minutes before en after the procedure of extrarenal purification, bloodletting or vascular filling
The correlation between ultrasound measurement of the VExUS score and the change in blood volume induced by extrarenal purification, bloodletting or vascular filling is studied. Ultrasound is performed before and after the procedure, each measure 3 times in succession, to establish the score.
University Hospital, Toulouse
Other
Evaluation of the Venous Excess Ultrasound Score (VExUS) After Circulating Volume Modification in Children. VExUS-Mod
Acronym: VExUS-Mod
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03635307
Blood Volume Expansion
Bordeaux, France
View Trial DetailsNCT07737366
Anxiety, Anxiety Disorders
Sakarya, Turkey (Türkiye)
View Trial DetailsNCT06095518
Cardiovascular Diseases, Embolism and Thrombosis
Hong Kong
View Trial DetailsNCT06192836
Cesarean Section Complications, Dystocia
Ankara, Turkey (Türkiye)
View Trial Details